Retatrutide – 30mg

Retatrutide is a triple-acting glucagon-like peptide receptor agonist that targets GLP-1, GIP, and glucagon receptors. This 30mg formulation is suited for initial research protocols and dose-finding studies investigating multi-receptor metabolic modulation.

The triple agonist approach represents an emerging research frontier in metabolic science. By simultaneously engaging three key receptors in energy homeostasis, GLP3-RT enables investigations into synergistic signaling effects on glucose metabolism, lipid processing, and appetite-regulating neural circuits. Preclinical studies have explored how concurrent activation of these pathways may differ from sequential or isolated receptor stimulation.

Each vial contains 30mg of lyophilized GLP3-RT, manufactured under strict GMP conditions. Purity is verified at greater than 98% via HPLC analysis, with mass spectrometry and endotoxin testing as additional quality controls. Certificate of analysis available upon request.

Storage: Store lyophilized at -20°C. Reconstituted at 2-8°C, use within 60 days.

For research and laboratory use only.